| Viral-human chimeric transcript predisposes risk to liver cancer development and progression CC Lau, T Sun, AKK Ching, M He, JW Li, AM Wong, NN Co, AWH Chan, ... Cancer cell 25 (3), 335-349, 2014 | 295 | 2014 |
| MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN LY Zhang, V Ho-Fun Lee, AMG Wong, DLW Kwong, YH Zhu, SS Dong, ... Carcinogenesis 34 (2), 454-463, 2013 | 224 | 2013 |
| Profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs AMG Wong, KL Kong, JWH Tsang, DLW Kwong, XY Guan Cancer 118 (3), 698-710, 2012 | 180 | 2012 |
| Personalized therapy for hepatocellular carcinoma: Where are we now? SL Chan, AM Wong, K Lee, N Wong, AKC Chan Cancer treatment reviews 45, 77-86, 2016 | 70 | 2016 |
| RBMS3 at 3p24 Inhibits Nasopharyngeal Carcinoma Development via Inhibiting Cell Proliferation, Angiogenesis, and Inducing Apoptosis J Chen, DLW Kwong, CL Zhu, LL Chen, SS Dong, LY Zhang, J Tian, ... Public Library of Science 7 (9), e44636, 2012 | 49 | 2012 |
| Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma AMG Wong, KL Kong, L Chen, M Liu, AMG Wong, C Zhu, JW Tsang, ... International journal of cancer 133 (10), 2284-2295, 2013 | 43 | 2013 |
| Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy? HHF Loong, AM Wong, DTM Chan, MSH Cheung, C Chow, X Ding, ... Journal of Clinical Neuroscience 78, 400-402, 2020 | 39 | 2020 |
| Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese Y Li, L Fu, AMG Wong, YH Fan, MX Li, JX Bei, WH Jia, YX Zeng, D Chan, ... PloS one 6 (1), e14562, 2011 | 24 | 2011 |
| Reply to profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs AMG Wong, JWH Tsang, XY Guan Cancer 118 (18), 4634-4635, 2012 | 20* | 2012 |
| Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion AM Wong, X Ding, AM Wong, M Xu, L Zhang, HHW Leung, AWH Chan, ... Journal of Hepatology, 2022 | 19 | 2022 |
| TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk YK Lam, J Yu, H Huang, X Ding, AM Wong, HH Leung, AW Chan, KK Ng, ... Hepatology, 2022 | 12 | 2022 |
| Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity M Xu, Y Liu, HL Wan, AM Wong, X Ding, W You, WS Lo, KKC Ng, N Wong Cancer Letters 548, 215898, 2022 | 7 | 2022 |
| Organoids in Lung Cancer Management Y Li, JWY Chan, RWH Lau, WWY Cheung, AM Wong, AM Wong, N Wong, ... Frontiers in Surgery 8, 2021 | 6 | 2021 |
